Schedule 13G ownership disclosure

REGENXBIO Inc

Common Stock, par value $0.0001 per share · CUSIP: 75901B107

Event date: 2024-12-31

Filing-level shares
3,698,862.0
Percent of class
7.4%
  • JPMORGAN CHASE & CO.

    Shares: 3,698,862.0 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000019617-25-000259
Form type
SCHEDULE 13G/A
Filer
JPMORGAN CHASE & CO
CIK
CIK 19617
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub